ASX-listed consumer healthcare company Wellnex Life Ltd has obtained an additional quotation on AIM. This will help it to finance growth outside of Australia.
The company has a range of its own brands and an agreement with Haleon to sell Panadol products. There are already significant revenues in Australia and potential in other markets, such as the UK and UAE.
On the first day of trading the share price was 31p, but it has declined since then. It has bottomed out at 24p, which is well below the flotation price. A loss is forecast for this year, but the shares are trading on a potential single...
AIM weekly movers: Strip Tinning’s recharged battery
Dr Graham Cooley has increased his stake in spirits company Distil (LON: DIS) from 16.2% to 17.3%. Steve Xerri had cut his shareholding from 3.78% to under 3%. The share price rebounded 50% to 0.0675p, although it is still 46% lower than at the start of the year.
Automotive and battery connectors supplier Strip Tinning (LON: STG) is expecting a lower than forecast loss in 2025 because of strong trading in the battery division. This is a higher margin part of the business, and it will help to reduce the EBITDA loss from £1.6m to £900,000. The anticipated lifetime value of an existing US battery connectors client has been raised from £43m to at least £56.8m. The overall market remains difficult, though. A £520,000 R&D tax credit should be received in April and another payment of £250,000 should be received in the second half of 2025. Strip Tinning is on course to make a pre-tax profit in 2027. A grant is being applied for from the Automotive Transformation Fund. Strip Tinning will require more cash to fund growth. The share price initially more than doubled and ended the week 29.7% ahead at 24p.
Insurance premium finance provider Orchard Funding (LON: ORCH) reported an improvement in pre-tax profit from £1.08m to £2.1m. Impairment provisions fell from £490,000 to £60,000. Average income earning assets grew 9% to £67.9m. There is an interim dividend of 1p/share plus a special dividend of 1p/share. The company is sceptical about AIM, but it has no current plans to leave. The share price is 28.1% higher at 36.5p.
Zinnwald Lithium (LON: ZNWD) shares benefited from the announcement that the Saxony state government has recognised the company’s eponymous lithium project as a project of outstanding importance. The company recently published a pre-feasibility study showing a pre-tax NPV of €3.3bn with a mine life of 40 years. The shares recovered one-quarter to 6p, which is slightly lower than at the start of the previous week, when disappointment about the project not being on the list of 47 projected designated strategic by the EU led to a fall in the share price.
FALLERS
Electric Guitar (LON: ELEG) returned from suspension during the week after creditors agreed to the company voluntary arrangement and a £300,000 subscription at 0.034p/share. The company liquidated its operating subsidiary and is seeking a new business to acquire. The share price declined 64.6% to 0.085p.
Minoan Group (LON: MIN) says trading in the shares is likely to be suspended because it does not have enough cash to complete the audit of its accounts to October 2024. The suspension is expected on 1 May, but it may come earlier because of the lack of cash. Minoan has not been able to extend the secured loan, totalling £1.19m, provided by DAGG. A proposal from DAG includes the conversion of the loan into shares and an additional £4.44m cash injection in return for shares. Some members of DAGG would also write off £1.1m they are owed. DAGG wants to nominate management to take the company forward. Investor concern knocked 61.5% off the share price to 0.125p.
Celadon Pharmaceuticals (LON: CEL) said it has still not received funds following its draw down request from either of its credit facilities. The company is talking to other finance providers. There is support from creditors to enable the cannabis medicines developer to continue to trade in April, but cash is required. The share price continued its slide ending the week 43.8% lower at 4.5p.
Cloud software services provider CloudCoCo (LON: CLCO) reported growth in ecommerce sales helping overall revenues to rise 6% to £27.5m in the year to September 2024. The revenues of continuing operations improved from £6.19m to £8.74m, while the loss fell from £603,000 to £553,000. Disposals since the year end have reduced debt. The results were published just in time to prevent trading in the shares being suspended. The share price dipped 41.9% to 0.09p.
Aquis weekly movers: Samarkand leaving Aquis
Tectonic Gold (LON: TTAU) says farm-in partner White Energy has completed stage 1 of its spending commitment and earned a 51% interest in Specimen Hill. A further $1m of spending will earn a further 25%. White Energy can then pay $2m to buy the minority shareholding, although Tectonic Gold will retain a 3% perpetual net smelter royalty. There were no revenues in the six months to December 2024. There was £119,000 in cash at the end of 2024. The share price is one-third higher at 0.2p.
Ormonde Mining (LON: ORM) investee company TRU Precious Metals Corp is going to drill test a pipeline of exploration targets at the Golden Rose project that has been optioned by Eldorado Gold Corporation. The share price increased 10.7% to 0.155p.
Invinity Energy Systems LON: (IES) has reached agreement to proceed with the LODES project, which is a 21MWh VS3 system co-located with a solar array. The total cost of the project is £20m. Planning permission has to be adjusted before the project can commence construction and the project could be completed and operating in the second half of 2026. There should be some revenues recognised in 2025. A loss is still forecast for this year despite a jump in forecast revenues to £35.5m. The share price rose 6.06% to 8.75p.
Ananda Pharma (LON: ANA) has received approval from the Alfed Hospital Human Research Ethics Committee in Australia for its phase 1 pharmacokinetic study of the lead cannabinoid drug candidate MRX1. The first patient should be dosed in the third quarter of 2025. The data can support regulatory filings in other countries. The share price is 5.88% higher at 0.45p.
Jonathan Neame bought 4,000 shares in Shepherd Neame (LON: SHEP) at 490p each. Richard Oldfield acquired 20,800 shares at 485p each and 5,000 shares at 484p each. The share price edged up 4.12% to 505p.
FALLERS
Samarkand (LON: SMK) is asking for shareholder approval to leave Aquis. The ecommerce technology provider has adapted its strategy to focus on its own brands and is less dependent on the Chinese market for growth. The costs of being quoted will be saved. The plan is to leave on 7 May and move to a JP Jenkins matched bargains facility. Even before the announcement, the lack of liquidity meant that the board does not believe the share price reflects the value of the business and it fell a further 82.1% to 0.625p.
ChallengerX has changed its name to Nyce International (LON: NYCE). The share price declined 22.2% to 0.175p.
AIM-quoted drug discovery company ImmuPharma (LON: IMM) has agreed to extend the period of warrants in Aquis-quoted skincare technology developer Incanthera (LON: INC). The 7.27 million warrants are exercisable at 9.5p each and they will be extended until the end of September. ImmuPharma will pay Incanthera a profit share of 30% of the difference between exercise and market prices. Incanthera has agreed to pay creditors £380,000 in shares at 8.5p each. The Incanthera share price dipped 20.9% to 8.5p.
KR1 (LON: KR1) had net assets of 58.2p/share at the end of February 2025. During February there was £462,000 of income generated from digital assets. The share price slid 18.4% to 31p.
Mendell Helium (LON: MDH) says the option to acquire Kansas-based M3 Helium has been extended to the end of June 2025. In principle, there is an offload agreement in principle with Scout Energy for the Rost well. The proceeds of this will fund the Hugoton farm-in agreement fee. The share price is 18.2% lower at 2.25p.
Automotive electrification technology developer Equipmake (LON: EQIP) has secured a £5m cash injection from Caterpillar Inc via convertible loan. This has an annual interest charge of 10% and lasts until the end of March 2029. The conversion price is the lower of 3.125p and 80% of the average trailing 30-day share price. There is also a development agreement for electric drivetrain products. This concludes the strategic review. An agreement with wave energy technology company CorPower Ocean will generate £650,000 for the first phase of the development of a generator and SiC (silicon carbide) inverter system to accelerate the commercialisation of the wave energy equipment. The share price dipped 17.9% to 1.15p.
Marula Mining (LON: MARU) has received the first revenues from sales of copper concentrate from the Kinusi copper mine in Tanzania. The share price decreased 17.1% to 3.625p.
Ride video capture technology provider Visum Technologies (LON: VIS) has extended its contract with the Children’s Day Foundation Linnanmaki in Finland for a further three years. This should generate a total of £100,000 in revenues. In the six months to December 2024, revenues fell from £130,000 to £71,000. The loss was $325,000. The share price declined 16.7% to 0.125p.
EPE Special Opportunities (LON: EO.P) has launched a share buyback programme of up to 2% of the shares in issue. The share price slipped 3.23% to 150p.
AIM movers: Shuka Minerals extends convertible and refinancing proposal for Minoan
Shuka Minerals (LON: SKA) has agreed with AUO Commercial Brokerage to extend the availability period for the entire £2m of the unsecured convertible note instrument to March 2026. The new redemption date is March 2027. Shuka Minerals is making progress towards the acquisition of the Kabwe mine. AUO has yet to provide any of the funding. The conversion price is 15p/share. The share price is two-fifths higher at 3.5p.
Shares in currency services provider Argentex (LON: AGFX) are continuing their upward momentum following full year figures earlier in the week. Chief executive Jim Ormonde bought 320,338 shares at 46.8p each. The outcome for 2024 was better than expected. Cash generated from operating activities improved from £13.6m to £16.7m. However, Argentex still fell into loss and may not return to pre-tax profit this year. Investment in digital infrastructure will help long-term growth. The share price rose a further 8.24% to 46p.
Keras Resources (LON: KRS) says the Togo state-owned company that has a mining permit for the Nayega manganese mine has appointed a contact miner and agreed an offtake deal with Fujax. Keras has advisory and brokerage agreements that entitle it to an advisory fee of 1.5% of gross revenues generated by the Nayega mine for three years and 6% of gross revenues for brokerage services over the lesser of 3.5 years and 900,000 tonnes of manganese ore produced and sold. The share price improved 7.69% to 1.4p.
Video editing technology developer Blackbird (LON: BIRD) reported a dip in revenues from £1.94m to £1.61m because of a lost contract. Operating costs were reduced. There was a £2.4m outflow from operating activities and there is £3.77m of cash in the balance sheet. Blackbird has already gained around 100 subscribers to the online collaborative editing platform elevate.io since its recent full launch and there are more than one thousand users. Blackbird has secured total revenues of £960,000 for 2025. That is lower than the same time in the previous year because that included a deal for the Olympics. The share price recovered 7.41% to 3.625p.
FALLERS
Minoan Group (LON: MIN) says trading in the shares is likely to be suspended because it does not have enough cash to complete the audit of its accounts to October 2024. The suspension is expected on 1 May, but it may come earlier because of the lack of cash. Minoan has not bee able to extend the secured loan, totalling £1.19m, provided by DAGG. A proposal from DAG includes the conversion of the loan into shares and an additional £4.44m cash injection in return for shares. Some members of DAGG would also write off £1.1m they are owed. DAGG wants to nominate management to take the company forward. The share price slumped 61.5% to 0.125p.
Beowulf Mining (LON: BEM) has revealed the full terms of its previously announced fundraising. A placing and rights issue could raise up to £4m and a retail offer could raise up to £700,000 at 11/share. The first £100,000 of the retail offer is subject to clawback relating to the placing. The WRAP retail offer will have a subscription period between 16 April and 2 May. The share price declined 35% to 13p.
Cleantech Lithium (LON: CTL) says the special lithium operating contract application process for the Laguna Verde project is taking longer than anticipated. The response to the application was expected in early April, but there is not indication of when it will happen. The share price fell 5.13% to 9.25p.
FTSE 100 resilience disintegrates as banks sink, China announces retaliatory measures
The FTSE 100 showed remarkable resilience yesterday in the initial reaction to Donald Trump’s trade tariffs, outperforming most European and US indices.
However, this resilience disappeared on Friday as FTSE 100 banking shares crumbled, sending the index sharply lower. Barclays, HSBC, Lloyds, Standard Chartered and NatWest all fell more than 5%.
Standard Chartered is the FTSE 100’s biggest casualty of the tariffs, losing around 17% of its value over the past week.
There were also losses for mining stocks and oil majors on Friday, which culminated in sending London’s leading index down by more than 3%.
Selling picked up after reports that China would implement 34% retaliatory tariffs on US goods and trade restrictions on rare earths. Investors will fear that more countries follow suit and take retaliatory measures. Some European leaders have been vocal in their support for hitting back at Trump.
Meanwhile, Donald Trump has said he’s open to negotiation. Equity bulls will hope the bookmaker-style charts of tariffs revealed on Wednesday were a PR stunt for his core voter base and an extreme negotiating tactic that will spur favourable trade deals.
Whatever the underlying motives are, markets are taking the tariffs on face value after a period of complacency, and the reaction in global equities has been cataclysmic.
Some economists are now predicting a US recession.
“With markets having suffered their worst week in five years, investors were hiding under their duvet on Friday hoping the pain would go away,” said Russ Mould, investment director at AJ Bell.
“Unfortunately, the relentless selling continued, with markets falling across Asia and Europe and futures prices implying the US will do the same when trading begins later on.
“There are so many moving parts that getting your head around the situation isn’t easy. With countless sectors set to be hit by tariffs, it’s difficult to know where to begin to comprehend the situation.”
US indices had their worst trading since the pandemic yesterday, and the selling showed little sign of easing. S&P 500 futures were 1% weaker in the premarket.
Legendary investor Bill Gross has warned against buying the dip. It appears, for today at least, investors are taking heed.
Cavendish enjoys strong growth in private markets
Cavendish plc, a leading UK investment bank, has reported expected revenues of approximately £55 million for the financial year ended 31 March 2025, in line with the previous year on a like-for-like basis.
The company maintained profitability throughout both halves of the financial year, demonstrating the appeal of its service offering across public and private markets.
Despite challenging market conditions, Cavendish increased its market share in public markets, completing the last UK IPO of 2024 and the first of 2025.
However, the general malaise in UK public markets has seen Cavendish increase their focus on the UK’s private markets where they have ongoing relationships with 150 UK private equity firms.
The firm said its private markets business delivered particularly strong revenue growth, reflecting the strength of its advisory capabilities and continued demand for high-quality execution in this segment.
Cavendish has recently opened offices in Manchester and Birmingham to strengthen their regional presence and better serve their private market clients.
The company enters the new financial year with £21 million in net cash and more active mandates than at the same point last year.
UK Deeptech, Quantum Computing, and PISCES with Amadeus Capital Partners
The UK Investor Magazine was delighted to welcome Nick Kingsbury, Partner at Amadeus Capital Partners, for a deep dive into early-stage UK deeptech companies and what the upcoming introduction of the PISCES private company trading venue means for the UK’s private markets.
Nick provides a fascinating insight into Amadeus Capital Partners’ investment strategy, paying particular attention to their approach to UK deeptech companies and the core characteristics they look for in portfolio companies.
We discuss a selection of exciting UK companies in the quantum computing space and the specific real-world solutions they provide.
The Private Intermittent Securities and Capital Exchange System, better known as PISCES, is set to launch this year in the UK, aiming to provide investors a venue for improved trading of unlisted shares.
We explore the purpose of PISCES, and Nick gives his views on the benefits for the UK’s private markets.
Kodal Minerals update fails to inspire investors
Kodal Minerals shares were unmoved by the latest update on the company’s lithium mining operations.
Despite Kodal Minerals’ Bougouni Lithium Project in Southern Mali reaching the significant production milestone of over 11,000 tonnes of spodumene concentrate, shares in the company were trading marginally lower at the time of writing on Friday.
The company is nearing completion of the Bougouni Lithium mine and is carrying out optimisation of the processing plant, preparing for full production.
“I am pleased to confirm that the ramp-up and optimisation of the Project and DMS processing plant is progressing and, positively, we are seeing ongoing improvements through the modifications and adjustments to the DMS processing plant as advancements continues,” said Bernard Aylward, CEO of Kodal Minerals.
The project, which achieved its first lithium spodumene concentrate in February 2025, has handled 13,400 tonnes of material, yielding 1,920 tonnes of spodumene concentrate with a grade of 5.63% Li₂O.
Despite this progress, export plans to China via the Port of Abidjan in Côte d’Ivoire remain on hold pending the transfer of the Bougouni Mining Licence from Future Minerals SARL to Les Mines de Lithium de Bougouni SA (LMLB). Whilst the necessary company structure updates have been completed and approved by relevant Mali Government ministers, the application awaits final approval from President Assimi Goïta. This is an issue that has now dragged on for months.
The licence transfer delay has prompted Kodal Mining (UK) Ltd, which holds a 49% interest in the project, to formally request an extension for its scheduled US$7.5 million payment to the Mali government, as outlined in the November 2024 Memorandum of Understanding. Government officials have acknowledged receipt of this request, though a formal response is still pending.
Although Kodal is moving towards full commercial production at Bougouni, the Kodal share price still hasn’t managed to build a base above levels seen in 2021.
AIM movers: Brighton Pier rebounds and ex-dividends
Shares in Brighton Pier (LON: PIER) rebounded 114.8% to 14.5p following the announcement of plans to ask shareholders for approval for an exit from AIM. It costs up to £300,000/year to be on the junior market and there is a lack of liquidity. It is difficult to raise significant amounts of money. There are plans to arrange a refinancing with two major shareholders. The leisure group intends to secure a matched bargain facility. The share price was 17.75p before the announcement.
Respiratory drugs developer Synairgen (LON: SNG) says that TFG Asset Management says it will waive its right of refusal on transfers of more than one million shares up until any further fundraising. TFG owns 86.9% of the company. The AIM admission will be cancelled on 9 April. An Asset Match facility has been secured for two years. The share price recovered 17% to 1.1p.
Strategic Minerals (LON: SML) generated revenues of $1.18m in the first quarter of 2025, which is year-on-year growth of 41%, from the Cobre magnetite operation in New Mexico. The group had $530,000 in the bank. The share price increased 6.67% to 0.4p.
Shares in Zinnwald Lithium (LON: ZNWD) continue to rise following yesterday’s announcement that the Saxony state government has recognised the company’s eponymous lithium project as a project of outstanding importance. The company recently published a pre-feasibility study showing a pre-tax NPV of €3.3bn with a mine life of 40 years. The share price rose 5.93% to 6.25p.
Cambridge Cognition (LON: COG) is providing digital cognitive and voice assessments for two phase 3 clinical trials in adolescents with clinical depressive. The combined value of the contracts, which last until 2027 and 2029 respectively, is £1.2m. This will help Cambridge Cognition to meet 2025 revenue expectations of £12.5m, which would return the company to profit. The share price improved 4.17% to 37.5p.
FALLERS
Oracle Power (LON: ORCP) says assay results for five holes from the Northern Zone gold project in Western Australia and four have highlighted results. These confirm and enlarge the shallow gold mineralisation. Samples from four other holes are still be analysed and reported on. The share price declined 11.9% to 0.0185p.
Cancer treatments developer ValiRx (LON: VAL) has terminated its exclusivity agreement with TheoremRx Inc and ValiRx will move the VAL201 prospect to a prostate cancer focused special purpose vehicle. There is interest from a consortium and charities regarding possible support for development. The share price fell 10.5% to 0.425p.
K3 Technology (LON: KBT) intends to return £29m – equivalent to 64.8p/share – to shareholders via tender following a recent disposal and it is consulting with shareholders about whether to remain on AIM. The software company will still have £6m in cash and remaining software businesses that are a Microsoft Dynamics fashion industry partner and a supplier of software to IKEA. The share price slipped 6.32% to 89p.
Ex-dividends
Caledonia Mining Corporation (LON: CMCL) is paying a dividend of 14 cents/share and the share price rose 50p to 925p.
IDOX (LON: IDOX) is paying a final dividend of 0.7p/share and the share price declined 1.8p to 55.8p.
Personal Group Holdings (LON: PGH) is paying a final dividend of 10p/share and the share price fell 16p to 233p.
Quartix Holdings (LON: QTX) is paying a final dividend of 3p/share and the share price slipped 4p to 193p.
Real Estate Investors (LON: RLE) is paying a dividend of 0.4p/share and the share price is unchanged at 30p.
Three S&P 500 shares to consider after Trump’s tariffs by Hargreaves Lansdown
The S&P 500 is firmly in correction territory after the announcement of tariffs on America’s trading partners sent global equities sharply lower.
Indeed, the S&P 500 was one of the most heavily hit indices in the immediate reaction. Some investors may see this as a buying opportunity for some of the world’s leading companies.
Derren Nathan, head of equity research at Hargreaves Lansdown, has picked out three S&P 500 companies for consideration in the wake of tariff-induced sell-off.
In his own words, Nathan outlines three US shares he has his eye on:
GE Healthcare – imaging a brighter future
“GE Healthcare is a top-tier provider of medical technology. It has a leading position in imaging equipment like X-ray machines and MRI scanners. This is the biggest part of the business and leaves it well-placed to address the ageing global population and the demand for early detection of cancer and other illnesses.
It’s not all about lumpy, expensive hardware sales though. There are a host of consumables and software add-ons that help smooth the revenue profile. The huge volumes of data generated by medical imaging tests mean there’s plenty of scope for artificial intelligence (AI) to improve patient outcomes and efficiency within healthcare systems. It’s an opportunity the company is pursuing aggressively, and GE is already generating commercial traction.
GE closed out 2024 with a quarter of modest revenue growth and margins expanding quicker than guided. Headwinds in China weren’t enough to offset growth elsewhere, but it’s something to keep an eye on especially as trade tensions mount. However, China’s a relatively small part of the revenue mix, with North America by far the largest region by revenue. Economic uncertainty is also building in the US, but essential diagnostic services tend to be relatively resilient to cyclical ups and downs.
Overall, organic revenue growth is expected to improve this year. And there’s hope for further progress towards the medium-term target of operating profit margins approaching 20%, driven by efficiency gains and product innovations. To achieve all this, GE spends over $1bn a year on Research & Development, but that’s supported by healthy cash flows and a strong balance sheet. The high pace of innovation carries some execution risk. But the valuation doesn’t look too demanding, and investors could be rewarded if the plan can be delivered.
Nvidia – AI leadership credentials intact
Despite another set of forecast-beating earnings, as well as better-than-expected guidance for the current quarter, NVIDIA’s valuation has slid further below the long-term average so far this year.
We think it’s been caught up in the wider pivot towards more defensive sectors. But it also reflects concerns about trade restrictions and the scale of future demand for NVIDIA’s powerful computer processors.
We’re encouraged by the innovations set out at the company’s recent developer conference. The group looks well positioned to retain its leadership in computing for AI as the focus moves from the training of models to reasoning in real-time or inference. While there are some meaningful rivals emerging in the inference space, NVIDIA offers a compelling solution to its customers.
It’s not just the chips that make NVIDIA’s product so appealing, the CUDA software platform that enables users to optimise the hardware is key. AI has the scope to transform practically every industry, and NVIDIA is proving to be a key partner in everything from healthcare through to self-driving vehicles.
However, the ability to scale does depend on key partners. While recent production constraints seem to have been addressed, there’s no guarantee the supply chain will continue to keep up with soaring demand. That said, the next iteration of the company’s commuting architecture is expected to be less challenging to roll out.
CEO Jensen Huang thinks there’s scope for revenues to grow more than five-fold to $1trn by 2028, but it’s too early to say how likely that is. In the near term, forecasts for revenue to nearly treble to over $250bn by the end of the next financial year don’t feel unreasonable. On that basis, prospective earnings multiple of 25x looks attractive. But the company is under immense scrutiny, so any missteps are likely to be punished.
A party connected to the author owns shares in NVIDIA
Uber – from rides to riches
Uber, America’s leading ride-hailing service, is transitioning into a global transportation powerhouse, offering food delivery and freight services. Its asset-light model connects drivers and riders, delivering better value and service as user numbers grow and the network broadens. Thanks to its multi-service offering, Uber’s ride-hailing, delivery, and freight services attract a broad range of customers. Many Uber Eats users come from the rides app and vice versa, which helps to keep more customers on the platform and boost overall usage and spending.
The ride-hailing arm is the main money-maker, and trends are improving here. It’s expanding into new regions, allowing fixed costs to be spread across more journeys. This helps them keep prices competitively low, win more rides, and increase drivers’ earnings – a key factor in growing its fleet and improving the user experience. There are some challenges though, including regulatory hurdles and ongoing disputes with local taxi drivers. Stiff competition can also lead to heavy price discounting. It’s important that Uber remains competitive on costs, without compromising on service levels or its variety of offerings to consumers.
Uber’s food delivery business is growing at pace, becoming profitable and expanding beyond food to groceries and other essentials. Advertising revenue in this division is expected to grow faster than order revenue, as Uber effectively targets user-centric ads based on habits.
Autonomous Vehicles (AV) are an emerging trend, and Uber plans to approach this by enabling AV partners to scale using their platform, rather than building vehicles themselves. We support this approach, but there’s a lot of execution risk ahead and no guarantee that partnerships will endure.
Uber has become a part of everyday life through its diverse range of offerings. The group’s growth profile, combined with improving margins and impressive cash generation, makes for a compelling proposition. That’s recognised by a forward earnings multiple in the high 20s. We think that’s merited by its strong competitive position and superior service offering. But it also means there’s some pressure to deliver in the face of economic uncertainty.”

